Company: RCUS
Filing Date: 2025-10-31
Form Type: 424B5
Source: 0001193125-25-260836
Chunk: 65

Company: Arcus Biosciences, Inc.
Filing Date: 2025-10-31
Form: 424B5
Chunk 65
---
 and/or the warrant agreement and warrant certificate, as applicable, and any supplemental agreements, that contain the terms of the warrants. General We will describe in the applicable prospectus supplement the terms of the series of warrants being offered, including:

| • |     | the offering price and aggregate number of warrants offered; |

| • |     | the currency for which the warrants may be purchased; |

| • |     | if applicable, the designation and terms of the securities with which the warrants are issued and the number of 
 warrants issued with each such security or each principal amount of such security;                              |

| • |     | in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon                                  
 exercise of one warrant and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise; |

| • |     | in the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or                                               
 preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise; |

| • |     | the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and 
 the warrants;                                                                                                    |

| • |     | the terms of any rights to redeem or call the warrants; |

| • |     | any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise 
 of the warrants;                                                                                                  |

| • |     | the dates on which the right to exercise the warrants will commence and expire; |

21

| • |     | the manner in which the warrant agreements and warrants may be modified; |

| • |     | a discussion of any material or special U.S. federal income tax considerations of holding or exercising the 
 warrants;                                                                                                   |

| • |     | the terms of the securities issuable upon exercise of the warrants; and |

| • |     | any other specific terms, preferences, rights or limitations of or restrictions on the warrants. |

Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including:

| • |     | in the case of warrants to purchase debt securities, the right to receive payments of principal of, or premium,               
 if any, or interest on, the debt securities purchasable upon exercise or to enforce covenants